[Serum bile acid level and cholic acid disappearance rate in alcoholic liver disease (author's transl)].

PubWeight™: 0.75‹?›

🔗 View Article (PMID 680472)

Published in Gastroenterol Clin Biol on May 01, 1978

Authors

R Y Poupon, R E Poupon, D Petit, R Infante, F Darnis

Articles by these authors

Comparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: a randomised open-label trial, the 2NN Study. Lancet (2004) 6.27

Magnetic domain-wall logic. Science (2005) 5.92

REM sleep behavior disorder and REM sleep without atonia in Parkinson's disease. Neurology (2002) 2.44

Receptor types in cat hairy skin supplied by myelinated fibers. J Neurophysiol (1968) 2.10

Determinants of outcome of compensated hepatitis C virus-related cirrhosis. Hepatology (1998) 2.06

Strongyloides stercoralis hyperinfection associated with human T cell lymphotropic virus type-1 infection in Peru. Am J Trop Med Hyg (1999) 1.95

Chronic active hepatitis associated with antiliver/kidney microsome antibody type 1: a second type of "autoimmune" hepatitis. Hepatology (1988) 1.79

Ursodeoxycholic acid for primary biliary cirrhosis: lessons from the past--issues for the future. J Hepatol (2000) 1.78

EEG and cardiac activation during periodic leg movements in sleep: support for a hierarchy of arousal responses. Neurology (1999) 1.62

Development of sleep patterns in early adolescence. J Sleep Res (2001) 1.61

Apolipoprotein E polymorphism, a marker of disease severity in primary biliary cirrhosis? J Hepatol (2001) 1.54

Is ursodeoxycholic acid an effective treatment for primary biliary cirrhosis? Lancet (1987) 1.52

Slow-wave activity in sleep apnea patients before and after continuous positive airway pressure treatment: contribution to daytime sleepiness. Chest (2001) 1.49

Sleep in menopause: differential effects of two forms of hormone replacement therapy. Menopause (2001) 1.48

Zinc tolerance and hyperaccumulation are genetically independent characters. Proc Biol Sci (1999) 1.44

The Soviet health system--aspects of relevance for medicine in the United States. N Engl J Med (1972) 1.43

Effect of pretransplantation ursodeoxycholic acid therapy on the outcome of liver transplantation in patients with primary biliary cirrhosis. Liver Transpl Surg (1999) 1.41

Recurrent acute calcium pyrophosphate dihydrate arthritis following intraarticular hyaluronate injection. Arthritis Rheum (1999) 1.41

The structure of vitellogenin provides a molecular model for the assembly and secretion of atherogenic lipoproteins. J Mol Biol (1999) 1.37

Sleep spindle characteristics in healthy subjects of different age groups. Clin Neurophysiol (2001) 1.34

Neurobiology of sleep disturbances in neurodegenerative disorders. Curr Pharm Des (2008) 1.24

Fast domain wall motion in magnetic comb structures. Nat Mater (2010) 1.23

Magnetization reversal in individual cobalt micro- and nanowires grown by focused-electron-beam-induced-deposition. Nanotechnology (2009) 1.16

Measuring domain wall fidelity lengths using a chirality filter. Phys Rev Lett (2009) 1.13

Dorsal column projection of receptors in cat hairy skin supplied by myelinated fibers. J Neurophysiol (1968) 1.12

Chronic cholestatic diseases. J Hepatol (2000) 1.11

Increased uptake of fatty acids by the isolated rat liver after raising the fatty acid binding protein concentration with clofibrate. Biochem Biophys Res Commun (1978) 1.09

Treatment of encephalopathy during fulminant hepatic failure by haemodialysis with high permeability membrane. Gut (1978) 1.07

The effect of ursodeoxycholic acid therapy on liver fibrosis progression in primary biliary cirrhosis. Hepatology (2000) 1.06

Sleep in Alzheimer's disease: further considerations on the role of brainstem and forebrain cholinergic populations in sleep-wake mechanisms. Sleep (1995) 1.04

Prognostic value of serum hyaluronan in patients with compensated HCV cirrhosis. J Hepatol (2000) 1.04

Relationship between procollagen III aminoterminal propeptide and hyaluronan serum levels and histological fibrosis in primary biliary cirrhosis and chronic viral hepatitis C. J Hepatol (1994) 1.03

Drug-induced hepatitis associated with anticytoplasmic organelle autoantibodies. Hepatology (1985) 1.03

Report of the first cases of cutaneous leishmaniasis in East Timor. Clin Infect Dis (2000) 1.01

Pramipexole in the treatment of restless legs syndrome: a follow-up study. Eur J Neurol (2000) 1.00

Lipid and lipoprotein metabolism in Hep G2 cells. Biochim Biophys Acta (1988) 0.99

Liver adenoma and focal nodular hyperplasia in a man with high endogenous sex steroids. Gastroenterology (1987) 0.99

A family with the Bardet-Biedl syndrome and diabetes mellitus. Arch Ophthalmol (1989) 0.98

A bulbar relay to the centre median. J Neurophysiol (1968) 0.98

Spontaneous separation in idiopathic vitreomacular traction syndrome associated with contralateral full-thickness macular hole. Eur J Ophthalmol (2006) 0.98

Serum hyaluronan as a marker of liver fibrosis. J Hepatol (1995) 0.97

Effects of obstructive sleep apnea on cognitive function: a comparison between younger and older OSAS patients. Sleep Med (2007) 0.97

[Biosynthesis of plasma lipoproteins by the regenerating liver]. Biochim Biophys Acta (1969) 0.96

Domain wall interactions at a cross-shaped vertex. Philos Trans A Math Phys Eng Sci (2012) 0.95

Daytime sleepiness and EEG spectral analysis in apneic patients before and after treatment with continuous positive airway pressure. Chest (2001) 0.95

Histopathological study of primary biliary cirrhosis and the effect of ursodeoxycholic acid treatment on histology progression. Hepatology (1999) 0.95

Near-field interaction between domain walls in adjacent Permalloy nanowires. Phys Rev Lett (2009) 0.94

Ursodeoxycholic acid therapy of chronic cholestatic conditions in adults and children. Pharmacol Ther (1995) 0.94

Serum bile acids and cholestasis in alcoholic hepatitis. Relationship with usual liver tests and histological features. J Hepatol (1994) 0.94

HBV genotypic resistance to lamivudine in kidney recipients and hemodialyzed patients. Transplantation (2000) 0.93

The healing of colonic anastomoses after early intraperitoneal chemotherapy: an experimental study in rats. J Surg Res (1988) 0.93

Preventive therapy of first gastrointestinal bleeding in patients with cirrhosis: results of a controlled trial comparing propranolol, endoscopic sclerotherapy and placebo. Hepatology (1990) 0.92

Outcomes of vitreoretinal surgery for retinal detachment after LASIK for myopia. Eur J Ophthalmol (2006) 0.91

[Fulminant hepatitis: an experience based on 137 cases. I. Complications (author's transl)]. Gastroenterol Clin Biol (1977) 0.91

Sleep and quantitative EEG in patients with progressive supranuclear palsy. Neurology (1997) 0.90

Circulating albumin messenger RNA in hepatocellular carcinoma: results of a multicenter prospective study. Hepatology (1997) 0.90

[Tienilic acid-induced hepatitis associated with liver/kidney microsomal antibody (author's transl)]. Nouv Presse Med (1980) 0.89

Clinical significance of serum bilirubin levels under ursodeoxycholic acid therapy in patients with primary biliary cirrhosis. Hepatology (1999) 0.89

Description of two different patients with abetalipoproteinemia: synthesis of a normal-sized apolipoprotein B-48 in intestinal organ culture. J Lipid Res (1990) 0.89

Biochemical evidence that Na+,K+-ATPase is located at the lateral region of the hepatocyte surface membrane. FEBS Lett (1979) 0.89

Expression of blood group antigens including HLA markers in human adult liver. Tissue Antigens (1986) 0.89

Glucuronidation of bile acids in human liver, intestine and kidney. An in vitro study on hyodeoxycholic acid. FEBS Lett (1985) 0.88

Risk factors for cirrhosis in patients with chronic hepatitis C virus infection: results of a case-control study. Hepatology (1997) 0.88

Improvement of domain wall conduit properties in cobalt nanowires by global gallium irradiation. Nanotechnology (2013) 0.87

Hypobetalipoproteinemia with accumulation of an apoprotein B-like protein in intestinal cells. Immunoenzymatic and biochemical characterization of seven cases of Anderson's disease. J Clin Invest (1986) 0.87

Tunable remote pinning of domain walls in magnetic nanowires. Phys Rev Lett (2011) 0.87

[Encephalopathy in acute hepatic atrophy. Effect of the purification of middle molecules. Preliminary results]. Nouv Presse Med (1975) 0.87

Regulation of HMG-CoA reductase, apoprotein-B and LDL receptor gene expression by the hypocholesterolemic drugs simvastatin and ciprofibrate in Hep G2, human and rat hepatocytes. Biochim Biophys Acta (1992) 0.87

A rapid method for lecithin:cholesterol acyltransferase estimation in human serum. Scand J Clin Lab Invest Suppl (1978) 0.87

Homeostatic sleep regulation in patients with idiopathic hypersomnia. Clin Neurophysiol (2000) 0.86

Isolation, culture and characterization of adult human hepatocytes from surgical liver biopsies. Hepatology (1984) 0.86

Spectral analysis of wakefulness and REM sleep EEG in patients with sleep apnoea syndrome. Eur Respir J (1998) 0.85

Association between waking EEG slowing and REM sleep behavior disorder in PD without dementia. Neurology (2004) 0.85

Probing the surface area of a cement-based material by nuclear magnetic relaxation dispersion. Phys Rev Lett (2003) 0.85

Postsynaptic fibres in the dorsal columns and their relay in the nucleus gracilis. Brain Res (1972) 0.85

Tea brewed in traditional metallic teapots as a significant source of lead, nickel and other chemical elements. Food Addit Contam Part A Chem Anal Control Expo Risk Assess (2011) 0.85

Intestinal absorption, excretion, and biotransformation of hyodeoxycholic acid in man. J Lipid Res (1983) 0.84

beta-Muricholic acid; potentiometric and cholesterol-dissolving properties. Biochim Biophys Acta (1987) 0.84

Lipid metabolism of rat liver isolated and perfused in hypoxia. Biomedicine (1974) 0.84

Effect of a single insulin administration on the hepatic release of triglycerides into the plasma. Biochim Biophys Acta (1973) 0.84

Long-term treatment with pramipexole in restless legs syndrome. Eur J Neurol (2006) 0.84

Isolation of rat hepatocytes with EDTA and their metabolic functions in primary culture. In Vitro Cell Dev Biol (1985) 0.83

The influence of vasoactive agents on metabolic activity of the liver in cirrhosis: a study of the effects of posterior pituitary extract, vasopressin, and somatostatin. Hepatology (1984) 0.83

A study of the microheterogeneity of transferrin in cirrhotic patients. Clin Chim Acta (1985) 0.82

Monoclonal antibody specific for an activated RAS protein. Proc Natl Acad Sci U S A (1986) 0.82

[Hepatic lesions due to perhexiline maleate (author's transl)]. Gastroenterol Clin Biol (1978) 0.82

Effect of vasodilators on hepatic microcirculation in cirrhosis: a study in the isolated perfused rat liver. Hepatology (1989) 0.82

Fasting serum bile acid level in cirrhosis. A semi-quantitative index of hepatic function. J Hepatol (1985) 0.82

Can hepatocytes proliferate when transplanted into the spleen? Demonstration by autohistoradiography in the rat. Eur Surg Res (1987) 0.81

[Demonstration of fibers with postsynaptic activity at the level of dorsal columns in cats]. J Physiol (Paris) (1969) 0.81

Mechanisms for reduced hepatic clearance and elevated plasma levels of bile acids in cirrhosis. A study in patients with an end-to-side portacaval shunt. Gastroenterology (1981) 0.81

Treatment of primary biliary cirrhosis. Baillieres Best Pract Res Clin Gastroenterol (2000) 0.81

Genotypic diversity revealed by allozymes and oligonucleotide DNA fingerprinting in French populations of the aquatic macrophyte Sparganium erectum. Mol Ecol (1996) 0.81

Effect of dihydrotestosterone on the rate of ethanol elimination in healthy men. Alcohol Clin Exp Res (1991) 0.81

Treatment of severe alcoholic hepatitis by infusion of insulin and glucagon: a multicenter sequential trial. Hepatology (1992) 0.81

In vitro synthesis of apo-A-IV and apo-C by liver and intestinal mRNAs from lean and obese Zucker rats. Biochem Biophys Res Commun (1987) 0.81